Medical Equipment

Global Cardiovascular Surgery Devices And Equipment Market Size and Forecast to 2029: Revenue, Growth, and Trends

December 8, 2025 by Marketing Posting

Uncover key drivers, emerging technologies, and competitive movements shaping the cardiovascular surgery devices and equipment market from 2025–2034 with trusted insights from The Business Research Company

How Big Is The Cardiovascular Surgery Devices And Equipment Market Size Today And What Will Its Value Be At The End Of 2029?

The cardiovascular surgery devices and equipment market has demonstrated consistent expansion in recent years. This market is projected to expand from $1.76 billion in 2024 to $1.8 billion in 2025, exhibiting a compound annual growth rate (CAGR) of 2.7%. The growth observed historically can be ascribed to the widespread prevalence of cardiovascular diseases, ongoing technological advancements, an aging global population, and improved chronic disease management.

The market for cardiovascular surgery devices and equipment is projected to experience consistent expansion over the upcoming years. By 2029, this market is anticipated to reach a valuation of $1.97 billion, expanding at a compound annual growth rate (CAGR) of 2.2%. Key drivers for this growth during the forecast period include the increasing adoption of minimally invasive surgery, advancements in imaging techniques, the rise of personalized medicine, and the growing use of telemedicine and teleconsultations. Significant trends identified for the same period encompass the development of hybrid operating rooms, the increase in transcatheter procedures, the integration of artificial intelligence (AI) in surgical practices, and the emergence of remote surgical training.

Access A Free Sample Of The Report:

https://www.thebusinessresearchcompany.com/sample.aspx?id=2389&type=smp

Which Key Drivers Are Powering Growth In The Cardiovascular Surgery Devices And Equipment Market?

The growth in the geriatric population, coupled with an increase in deaths associated with cardiovascular disorders, is propelling the cardiovascular surgical devices market. According to the American Heart Association (AHA), approximately 43.7 million people in the US aged above 60 suffered from cardiovascular disorders. The AHA also reports that worldwide, deaths related to cardiac diseases total 17.3 million per year and are anticipated to surpass 23.6 million by 2030. These factors are leading to a greater number of surgeries being performed, thus driving the market.

Which Segment Categories Are Driving Maximum Growth In The Cardiovascular Surgery Devices And Equipment Market?

The cardiovascular surgery devices and equipmentmarket covered in this report is segmented –

1) By Product Type: Beating heart surgery systems, Cardiopulmonary Bypass Equipment, Cardiac Ablation Devices, Perfusion Disposables

2) By Application: Congenital Heart Defects, Cardiac Arrhythmia, Coronary Heart Disease, Congestive Heart Failure, Other Applications

3) By End User: Home and Ambulatory care, Hospitals, Diagnostic laboratories, Research Laboratories

Subsegments:

1) By Beating Heart Surgery Systems: Stabilization Systems, Tissue Stabilizers, Coronary Artery Bypass Surgery Systems, Other Beating Heart Surgery Devices

2) By Cardiopulmonary Bypass Equipment: Heart-Lung Machines, Oxygenators, Cannulas, Tubing Packs, Cardioplegia Delivery Systems, Other Cardiopulmonary Bypass Equipment

3) By Cardiac Ablation Devices: Radiofrequency Ablation Devices, Cryoablation Devices, Laser Ablation Devices, Microwave Ablation Devices, Other Cardiac Ablation Devices

4) By Perfusion Disposables: Blood Oxygenators, Perfusion Cannulas, Tubing Sets, Filters, Blood Reservoirs, Other Perfusion Disposables

Which Emerging Trends Are Reshaping The Cardiovascular Surgery Devices And Equipment Market Landscape?

Leading companies are allocating capital to businesses within the Cardiovascular Surgery Devices and Equipment market that are dedicated to creating novel solutions, such as CardioVisio for Atrial Fibrillation (AFib). These innovations seek to advance early diagnosis, improve patient results, and optimize treatment pathways. CardioVisio for Atrial Fibrillation (AFib) represents an advanced diagnostic and monitoring platform specifically designed for the detection and management of AFib, a prevalent form of irregular heart rhythm. Illustratively, in August 2023, GE HealthCare, a US-based medical technology company, released CardioVisio for Atrial Fibrillation (AFib), a digital clinical decision support utility intended to elevate precision care for those with AFib. This pioneering solution, unveiled at the ESC Congress 2023, consolidates longitudinal patient data from multiple origins, thereby furnishing clinicians with a holistic understanding of heart health. Through its provision of evidence-backed recommendations consistent with AFib guidelines, CardioVisio effectively streamlines clinical operations and strengthens adherence to best practices.

Who Are The Leading Companies Driving The Cardiovascular Surgery Devices And Equipment Market?

Major companies operating in the cardiovascular surgery devices and equipment market include Abbott Laboratories, Boston Scientific Corporation, Cook Medical, Abiomed Inc., Angiodynamics, Transmedics, Terumo cardiovascular systems corporation, Edwards Life Science Corporation, Medtronic plc, Cardinal Health, Cyberheart Incorporated, Medwaves Incorporated, Thoratec Corporation, Cordis Corporation, Getinge Group, Atrion Corporation, Sorin S.P.A., Biosensors International, Bioventrix Inc., Maquet GmbH & Co. KG, EndoPhotonix Inc., Krdium Inc., SEMMT Inc., Amaranth Medical, 3M Health Care, Abaxis Inc., Atlas Genetics, Becton Dickinson and Company, BioFire Diagnostics, bioMérieux, Bio-Rad Laboratories, Cepheid, Chembio Diagnostic Systems, EKF Diagnostics, GenMark Diagnostics, Hologic, LumiraDx, Mesa Biotech (a subsidiary of Thermo Fisher Scientific), Nova Biomedical, NOWDiagnostics, Opko Health, OraSure Technologies, QIAGEN, Roche Diagnostics, Sekisui Diagnostics, Siemens Healthineers, Sysmex Corporation, Thermo Fisher Scientific, Trividia Health, Trivitron Healthcare, Werfen S.A.

Download The Full Report Here:

https://www.thebusinessresearchcompany.com/report/cardiovascular-surgery-devices-and-equipment-global-market-report

Which Region Holds The Largest Share In The Cardiovascular Surgery Devices And Equipment Market Today?

North America was the largest region in the global cardiovascular surgery devices and equipment market in 2024. Western Europe was the second-largest region in the global cardiovascular surgery devices and equipment market. The regions covered in the cardiovascular surgery devices and equipment market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, and Africa.

Get A Report Customized For You Here:

https://www.thebusinessresearchcompany.com/customise?id=2389&type=smp

Browse Through More Reports Similar to the Global Cardiovascular Surgery Devices And Equipment Market 2025, By The Business Research Company

Cardiovascular Devices Global Market Report 2025

https://www.thebusinessresearchcompany.com/report/cardiovascular-devices-global-market-report

Cardiovascular Monitoring And Diagnostic Devices And Equipment Global Market Report 2025

https://www.thebusinessresearchcompany.com/report/cardiovascular-monitoring-and-diagnostic-devices-and-equipment-global-market-report

Cardiovascular Medical Lasers Global Market Report 2025

https://www.thebusinessresearchcompany.com/report/cardiovascular-medical-lasers-global-market-report

Get in touch with us:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas +1 310-496-7795